Clinical Trial Update: Genetics and Heart Health After Cancer Therapy

View source ↗

Summary

This completed clinical trial update examines how genetics influence heart health after cancer therapy, including BRCA1/BRCA2-related breast/ovarian cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Drug-induced Cardiomyopathy
• Heart Disease
• Hereditary Breast and Ovarian Cancer Syndrome

Snippet

Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: Breast Cancer, Hereditary Breast/Ovarian Cancer (brca1, Brca2) | Status: COMPLETED